Differentiated Thyroid Gland Carcinoma
6 clinical trials · Condition
◉ Watch Differentiated Thyroid Gland Carcinoma
| Record | Firm | Date |
|---|---|---|
| Evaluation of 18F-TFB PET/CT Scan in Patients With Differentiated Thyroid Cancer (NCT05575440) | Mayo Clinic | 2022-04-22 |
| Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer (NCT03914300) | National Cancer Institute (NCI) | 2020-02-10 |
| Lenvatinib and Iodine Therapy in Treating Patients With Radioactive Iodine-Sensitive Differentiated Thyroid Cancer (NCT03506048) | Emory University | 2019-01-16 |
| Effect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine Cancer (NCT02592356) | M.D. Anderson Cancer Center | 2015-11-16 |
| Sunitinib Malate in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by Surgery (NCT00381641) | National Cancer Institute (NCI) | 2006-08-29 |
Track Differentiated Thyroid Gland Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.